Alexa? Help pharma find patient solutions.
That’s what Merck & Co. is aiming for in its new partnership with Amazon Web Services to develop digital voice-enabled solutions for people living with chronic diseases.
Using Amazon Lex, the brains behind the Amazon Echo device and its well-known voice-enabled assistant Alexa, Merck plans to initially work on diabetes. Its first initiative will be a call to entrepreneurs, techies and industry types for an innovation challenge expected to begin within the next month.
The yet-to-be-named challenge will be run by strategy and innovation consultancy Luminary Labs. While specifics haven’t been released, the call to action will “be open to solutions broadly enough that innovators of all stripes can come up with really novel ideas but being narrow enough to provide guidance and carefully evaluate submissions,” said Sara Holoubek, founder and CEO of Luminary Labs.
An independent jury will evaluate the submissions based on their use of voice-enabled technology that addresses Type 2 diabetes patient issues.
This already ubiquitous home iOT will feature new skills, diabetes being just one. The potential for this is immeasurable. Alexa, enable health skills ! may bring you to a new 'Alexapedia'.
- See more at: http://www.merck.com/about/featured-stories/merck-amazon.html#sthash.jhSODHfG.dpuf